ASCEND BY NTHRYS
Research Abroad Products

Translational Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 61–72 of 200 project topics
Genomic Biomarker Discovery SaaS Platform
A cloud-based software platform that identifies and validates clinically actionable genomic biomarkers from multi-omics datasets using machine learning algorithms. This enables pharmaceutical and diagnostic companies to accelerate drug development, companion diagnostic creation, and personalized medicine strategies with proprietary biomarker IP.
Translational Genomics IP & Strategy Click to view more details →
Variant Interpretation and Reporting Commercial Service
A specialized clinical laboratory service that provides comprehensive interpretation of genetic variants with evidence-based classifications and actionable medical recommendations for patient care. This generates recurring revenue through CLIA-certified reporting contracts with healthcare systems, diagnostic labs, and precision medicine clinics.
Translational Genomics IP & Strategy Click to view more details →
Pharmacogenomics Testing and Decision Support Tool
An integrated diagnostic platform combining pharmacogenetic testing with AI-powered clinical decision support software for medication selection and dosing optimization. This creates B2B revenue streams through healthcare provider subscriptions, insurance reimbursement partnerships, and pharmaceutical co-marketing agreements.
Translational Genomics IP & Strategy Click to view more details →
Genomic Data Analytics and Integration Platform
Enterprise software that aggregates, normalizes, and analyzes genomic data from multiple sequencing platforms and sources into actionable clinical and research insights. This delivers SaaS revenue through tiered pricing models for biotech companies, research institutions, and healthcare systems requiring scalable data infrastructure.
Translational Genomics IP & Strategy Click to view more details →
Cancer Genome Profiling and Precision Oncology Service
A comprehensive tumor genomic profiling service identifying somatic mutations, copy number alterations, and therapeutic targets with clinical actionability reports for oncology treatment planning. This generates substantial revenue through CAP-accredited lab services, insurance reimbursement, and partnerships with oncology centers and pharmaceutical companies.
Translational Genomics IP & Strategy Click to view more details →
Rare Disease Genomic Diagnosis Commercial Laboratory
A specialized CLIA-certified laboratory offering whole exome and whole genome sequencing with expert interpretation for rare genetic disease diagnosis and management. This captures high-margin revenue through direct-to-consumer offerings, healthcare provider referrals, and insurance reimbursement for diagnostic genetic testing.
Translational Genomics IP & Strategy Click to view more details →
Polygenic Risk Score Development and Licensing Platform
A proprietary software platform that designs, validates, and operationalizes polygenic risk scores for complex diseases and consumer health applications with clinical utility. This enables multiple revenue streams through IP licensing to diagnostic companies, consumer health apps, and pharmaceutical firms developing preventive interventions.
Translational Genomics IP & Strategy Click to view more details →
Genomic Quality Control and Sequencing Optimization Software
Advanced software tools that monitor sequencing quality metrics, optimize experimental workflows, and ensure regulatory compliance across genomic testing pipelines in clinical labs. This delivers value through per-sample licensing fees, enterprise SaaS subscriptions, and integration partnerships with sequencing platform vendors and clinical laboratories.
Translational Genomics IP & Strategy Click to view more details →
Germline-Somatic Variant Linking and Cancer Risk Assessment
A sophisticated bioinformatics platform that identifies cancer predisposition variants and estimates lifetime risk through integrated germline and somatic genomic analysis. This generates revenue through clinical laboratory services, insurance reimbursement for genetic counseling, and B2B partnerships with oncology practices and preventive health organizations.
Translational Genomics IP & Strategy Click to view more details →
Genomic Reference Database and API Commercial Service
A comprehensive, regularly updated genomic knowledge base platform providing clinical variant annotations, gene function data, and disease associations via enterprise API access. This creates recurring SaaS revenue through tiered API subscriptions for diagnostic laboratories, pharmaceutical companies, research institutions, and clinical software vendors.
Translational Genomics IP & Strategy Click to view more details →
Genomic Data Integration Platforms for Clinical Decision Support
SaaS platforms that aggregate and harmonize genomic data from multiple sources into unified dashboards for clinicians and researchers. These platforms enable faster variant interpretation, reduce time-to-diagnosis, and generate recurring subscription revenue from healthcare systems and diagnostic laboratories.
Translational Genomics Market Intelligence Click to view more details →
AI-Powered Variant Annotation and Pathogenicity Prediction Tools
Commercial software solutions that use machine learning to automatically classify genetic variants and predict disease causation with clinical-grade accuracy. These tools reduce manual curation costs by 60-80% and create high-margin licensing opportunities for genomics service providers.
Translational Genomics Market Intelligence Click to view more details →